JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB131376

Anti-ETFDH antibody [3D1AC4AF3]

Be the first to review this product! Submit a review

|

(4 Publications)

Mouse Monoclonal ETFDH antibody. Suitable for Flow Cyt, WB, ICC/IF, IHC-P and reacts with Human, Mouse, Rat samples. Cited in 4 publications.

View Alternative Names

ETF-QO, ETF-ubiquinone oxidoreductase, Electron-transferring-flavoprotein dehydrogenase, ETF dehydrogenase, ETFDH

4 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ETFDH antibody [3D1AC4AF3] (AB131376)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ETFDH antibody [3D1AC4AF3] (AB131376)

IHC image of ETFDH staining in Human normal heart muscle formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab131376, 5μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

Immunocytochemistry/ Immunofluorescence - Anti-ETFDH antibody [3D1AC4AF3] (AB131376)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-ETFDH antibody [3D1AC4AF3] (AB131376)

Immunofluorescent analysis of ETFDH in HDFn cells.
The cells were paraformaldehyde fixed (4%, 20 minutes) and Triton X-100 permeabilized (0.1%, 15 minutes). The cells were then incubated with ab131376 at 5 µg/ml for 2 h at room temperature, or over night at 4°C. The secondary antibody was (red) Alexa Fluor® 594 Goat anti-Mouse IgG (H+L) used at a 1/1000 dilution for 1 h. 1% BSA was used as the blocking agent for all blocking steps. The target protein locates to the mitochondria.

Flow Cytometry - Anti-ETFDH antibody [3D1AC4AF3] (AB131376)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-ETFDH antibody [3D1AC4AF3] (AB131376)

Flow cytometric analysis of ETFDH in HeLa cells fixed and permeabilized with methanol and stained with 1 µg/mL of ab131376 (blue), or an equal amount of an isotype control antibody (red). 1% BSA was used as the blocking reagent for all the blocking steps.

Western blot - Anti-ETFDH antibody [3D1AC4AF3] (AB131376)
  • WB

Unknown

Western blot - Anti-ETFDH antibody [3D1AC4AF3] (AB131376)

The high background signal in Mouse tissue sample was caused by the direct reaction between the Mouse IgG in Mouse tissue preps and the Goat anti-Mouse secondary antibody.

All lanes:

Western blot - Anti-ETFDH antibody [3D1AC4AF3] (ab131376) at 1 µg/mL

Lane 1:

Molecular weight marker

Lane 2:

Human Liver Homogenate (HLH) at 10 µg

Lane 3:

Human Heart Homogenate (HHH) at 10 µg

Lane 4:

HepG2 Cell Lysate at 15 µg

Lane 5:

Hela Cell Lysate at 15 µg

Lane 6:

HDFn Cell Lysate at 15 µg

Lane 7:

SY5Y Cell Lysate at 15 µg

Lane 8:

Jurkat Cell Lysate at 15 µg

Lane 9:

Mouse Liver Homogenate (MLH) at 10 µg

Lane 10:

Mouse Heart Homogenate (MHH) at 10 µg

Lane 11:

Rat Liver Homogenate (RLH) at 10 µg

Lane 12:

Rat Heart Homogenate (RHH) at 10 µg

Lane 13:

Rat Brain Homogenate (RBH) at 10 µg

Lane 14:

Rat Kidney Homogenate (RLH) at 10 µg

Lane 15:

Rat Skeletal Muscle Homogenate (RSMH) at 10 µg

Secondary

All lanes:

Goat anti-Mouse AP at 1/3000 dilution

Predicted band size: 68 kDa

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

3D1AC4AF3

Isotype

IgG1

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

WB, IHC-P, Flow Cyt, ICC/IF

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1 µg/mL", "FlowCyt-species-notes": "<p>(cells fixed and permeabilized with methanol)</p><p><a href='/en-us/products/primary-antibodies/mouse-igg1-kappa-monoclonal-15-6e10a7-isotype-control-ab170190'>ab170190</a> - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.</p>", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "5 µg/mL", "ICCIF-species-notes": "<p>(paraformaldehyde fixed cells)</p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "5 µg/mL", "IHCP-species-notes": "<p></p>" }, "Mouse": { "FlowCyt-species-checked": "guaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Rat": { "FlowCyt-species-checked": "guaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Product details

Want a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com

Properties and storage information

Form
Liquid
Storage buffer
pH: 7.5 Preservative: 0.02% Sodium azide Constituents: 0.877% Sodium chloride, 0.357% HEPES
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

ETFDH also known as Electron Transfer Flavoprotein Dehydrogenase plays an important role in transferring electrons within the mitochondrial respiratory chain. With a molecular mass of approximately 65 kDa it is predominantly expressed in tissues with high energy demands such as muscle and liver. ETFDH operates as a component of the electron transport chain facilitating electron transfer from the electron transfer flavoprotein (ETF) to the ubiquinone pool.
Biological function summary

The action of ETFDH assists in fatty acid and amino acid metabolism. As part of the larger electron transport chain complex ETFDH partners with both ETF-alpha and ETF-beta subunits to facilitate electron transfer. This process is key in the oxidation of fatty acids particularly in the beta-oxidation pathway. The functional activity of ETFDH helps convert energy stored in macronutrients into adenosine triphosphate (ATP) a necessary energy currency in cells.

Pathways

ETFDH has a critical role in both the beta-oxidation of fatty acids and the catabolism of certain amino acids. Within these pathways it acts as an intersection between the mitochondria and cellular energy production. ETFDH operates with other proteins such as ACAD9 and ACADVL to ensure efficient energy conversion and maintain cellular homeostasis. These pathways highlight ETFDH's involvement in mitochondrial function and overall energy metabolism.

Mutations in the ETFDH gene are linked to conditions like multiple acyl-CoA dehydrogenase deficiency (MADD) and glutaric acidemia type II. These metabolic disorders arise from deficiencies in energy metabolism often leading to severe clinical symptoms. ETFDH's interaction with proteins like ACAD9 can influence the severity and onset of these conditions emphasizing its medical significance in metabolic health. Understanding ETFDH's operation provides insight into potential therapeutic targets for related metabolic diseases.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Accepts electrons from ETF and reduces ubiquinone.
See full target information ETFDH

Publications (4)

Recent publications for all applications. Explore the full list and refine your search

Orphanet journal of rare diseases 20:121 PubMed40075430

2025

Identification of ETFDH gene c. 487 + 2 T > A pathogenic variant and mechanisms for polycystic kidney in neonatal onset MADD.

Applications

Unspecified application

Species

Unspecified reactive species

Bijun Zhang,Dongyang Zhang,Feiyue Sun,Xinxin Si,Meng Luan,Rong He

Orphanet journal of rare diseases 19:15 PubMed38221620

2024

Clinical, biochemical, and genetic spectrum of MADD in a South African cohort: an ICGNMD study.

Applications

Unspecified application

Species

Unspecified reactive species

Michelle Bisschoff,Izelle Smuts,Marli Dercksen,Maryke Schoonen,Barend C Vorster,George van der Watt,Careni Spencer,Kireshnee Naidu,Franclo Henning,Surita Meldau,Robert McFarland,Robert W Taylor,Krutik Patel,Mahmoud R Fassad,Jana Vandrovcova,Ronald J A Wanders,Francois H van der Westhuizen

Journal of the neurological sciences 384:121-125 PubMed29249369

2017

A novel mutation in ETFDH manifesting as severe neonatal-onset multiple acyl-CoA dehydrogenase deficiency.

Applications

Unspecified application

Species

Unspecified reactive species

Francois H van der Westhuizen,Izelle Smuts,Engela Honey,Roan Louw,Maryke Schoonen,Lindi-Maryn Jonck,Marli Dercksen

PloS one 9:e112971 PubMed25397948

2014

Heart mitochondrial proteome study elucidates changes in cardiac energy metabolism and antioxidant PRDX3 in human dilated cardiomyopathy.

Applications

WB

Species

Human

Esther Roselló-Lletí,Estefanía Tarazón,María G Barderas,Ana Ortega,Manuel Otero,Maria Micaela Molina-Navarro,Francisca Lago,Jose Ramón González-Juanatey,Antonio Salvador,Manuel Portolés,Miguel Rivera
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com